Landiolol HCl

CAS: 144481-98-1

Ref. 3D-FL33612

Produktinformation

• Name: Landiolol HCl
• Synonyme: Benzenepropanoic acid, 4-[(2S)-2-hydroxy-3-[[2-[(4-morpholinylcarbonyl)amino]ethyl]amino]propoxy]-, [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl ester, hydrochloride (1:1), Benzenepropanoic acid, 4-[(2S)-2-hydroxy-3-[[2-[(4-morpholinylcarbonyl)amino]ethyl]amino]propoxy]-, [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl ester, monohydrochloride, Benzenepropanoic acid, 4-[2-hydroxy-3-[[2-[(4-morpholinylcarbonyl)amino]ethyl]amino]propoxy]-, (2,2-dimethyl-1,3-dioxolan-4-yl)methyl ester, monohydrochloride, [S-(R*,R*)]-, Corebeta, ONO 1101 hydrochloride, Onoact, Rapibloc, [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-(4-{[(2S)-2-hydroxy-3-({2-[(morpholin-4-ylcarbonyl)amino]ethyl}amino)propyl]oxy}phenyl)propanoate hydrochloride (1:1), [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate hydrochloride, Landiolol hydrochloride

Beschreibung

Landiolol hydrochloride is a cardiac agent that has been shown to increase the force of contraction and decrease the heart rate. Landiolol HCl also lowers blood pressure, increases coronary blood flow, and reduces the workload on the heart. Landiolol HCl is used to treat congestive heart failure, angina pectoris, and arrhythmias. Landiolol HCl works by inhibiting phosphodiesterase enzymes in the myocardium and vascular smooth muscle cells that are responsible for breaking down cAMP. This leads to an increase in cAMP levels in these cells, which causes an increase in intracellular calcium levels and increased contractility of cardiac muscle. Landiolol HCl is not particularly toxic; it does not cause respiratory depression or other major side effects at therapeutic doses.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 546.05 g/mol
• Formel: C₂₅H₃₉N₃O₈·ClH
• Reinheit: Min. 95%